Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients.
第一作者:
Daniela,Massi
第一单位:
Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Italy.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗原, CD(Antigens, CD);女(雌)性(Female);叉头转录因子类(Forkhead Transcription Factors);人类(Humans);咪唑类(Imidazoles);吲哚类(Indoles);整合素α链(Integrin alpha Chains);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);男(雄)性(Male);黑色素瘤(Melanoma);中年人(Middle Aged);丝裂原激活蛋白激酶激酶类(Mitogen-Activated Protein Kinase Kinases);肟类(Oximes);预后(Prognosis);前瞻性研究(Prospective Studies);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);吡啶酮类(Pyridones);嘧啶酮类(Pyrimidinones);皮肤肿瘤(Skin Neoplasms);磺胺类(Sulfonamides);治疗结果(Treatment Outcome);青年人(Young Adult);β连环素(beta Catenin)
DOI
10.1016/j.ejca.2017.03.012
PMID
28412591
发布时间
2021-01-05
- 浏览35
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文